Ikarian Capital »

Cartesian Therapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $6.5M 242k 27.01

More positions owned by Ikarian Capital

Sarepta Therapeutics Call Option (SRPT)
Amgen Call Option (AMGN)
Bridgebio Pharma Call Option (BBIO)
Immunovant Call Option (IMVT)
Neurocrine Biosciences Call Option (NBIX)
Pyxis Oncology Common Stock Call Option (PYXS)
Insmed Com Par $.01 Call Option (INSM)
Abeona Therapeutics Com New Call Option (ABEO)
Alnylam Pharmaceuticals Put Option (ALNY)
Aerovate Therapeutics Call Option (AVTE)
Rapt Therapeutics Call Option (RAPT)
Praxis Precision Medicines I Com New Call Option (PRAX)
Crinetics Pharmaceuticals In (CRNX)
Tarsus Pharmaceuticals (TARS)
Soleno Therapeutics (SLNO)

View all positions for Ikarian Capital

Top funds holding Cartesian Therapeutics

BlackRock
Jpmorgan Chase & Co
Artal Group
MPM Oncology Impact Management
Ikarian Capital
Vanguard Group
State Street Corporation
Geode Capital Management
Logos Global Management
Nuveen Asset Management
Marshall Wace
Sphera Funds Management
Delphi Financial
Charles Schwab Investment Management
Renaissance Technologies

View all funds holding Cartesian Therapeutics